{
  "version": "1.0",
  "last_updated": "2026-05-06",
  "organization": "CheckMyGLP",
  "url": "https://checkmyglp.com",
  "service_type": "GLP-1 Eligibility Screening + Personalized Readiness Report",
  "pricing_model": "Free",
  "services": [
    {
      "id": "glp1-eligibility-calculator",
      "name": "GLP-1 Eligibility Calculator",
      "description": "Free 90-second 6-step web calculator that applies FDA weight-management criteria (BMI ≥30 OR BMI ≥27 with qualifying comorbidity) and returns an instant color-coded verdict with a live candidacy meter.",
      "url": "https://checkmyglp.com/#calc",
      "category": "primary",
      "features": {
        "cost": "Free",
        "credit_card_required": false,
        "signup_required": false,
        "completion_time": "~90 seconds",
        "step_count": 6,
        "live_candidacy_meter": true,
        "instant_verdict": true,
        "color_coded": true,
        "input_units": "metric or imperial"
      },
      "fields_collected": [
        "height",
        "weight",
        "age",
        "biological_sex",
        "waist_circumference (optional)",
        "comorbidities (multi-select)",
        "past_attempts (multi-select)",
        "current_medications (free text)",
        "goal_weight",
        "timeline_months"
      ]
    },
    {
      "id": "personalized-readiness-report",
      "name": "Personalized GLP-1 Readiness Report",
      "description": "Server-side AI-written report tailored to the user's exact profile. Emailed in seconds with PDF attached.",
      "category": "primary",
      "delivery": "email + PDF attachment",
      "generation": "server-side at request time using Anthropic Claude",
      "features": {
        "cost": "Free",
        "personalization": "AI-written prose (not template fill-in)",
        "pdf_attached": true,
        "verdict_categories": ["Likely Candidate", "Borderline", "Below Threshold"],
        "trial_citations": ["STEP (semaglutide)", "SURMOUNT (tirzepatide)"],
        "cost_paths_covered": ["Insurance-covered", "Cash-pay brand", "Licensed compounded"],
        "next_step_matched_to_verdict": true
      },
      "report_sections": [
        "Your numbers (BMI, category, FDA threshold position)",
        "What it means (personalized AI explanation)",
        "Your candidacy (verdict + applied criterion)",
        "Realistic expectations (trial-grounded outcome ranges)",
        "Three honest paths to access",
        "Your next step (matched to verdict)"
      ]
    },
    {
      "id": "concierge-chatbot",
      "name": "GLP-1 Eligibility Concierge Chatbot",
      "description": "Floating chat widget answering eligibility, cost, and safety questions. Context-aware once user has filled basic calculator info. Educational only.",
      "url": "https://checkmyglp.com/",
      "category": "product",
      "features": {
        "cost": "Free",
        "intents_allowed": ["eligibility", "cost", "safety"],
        "intents_refused": ["dosing advice", "prescription requests", "off-topic medical advice"],
        "context_aware": "Once height/weight is filled, the chatbot can reference user profile",
        "model": "Anthropic Claude (server-side)"
      }
    },
    {
      "id": "educational-email-drip",
      "name": "Educational Email Series (7 touches over 14 days)",
      "description": "Post-report email series covering GLP-1 mechanism, medication comparisons, patient stories (composite), objections, and cost. Single-click unsubscribe in every email.",
      "category": "service",
      "features": {
        "cost": "Free",
        "touches": 7,
        "duration_days": 14,
        "unsubscribe": "single-click, every email",
        "can_spam_compliant": true
      },
      "schedule": [
        {"day": 0, "topic": "Welcome + guide delivery"},
        {"day": 1, "topic": "How GLP-1 actually works"},
        {"day": 3, "topic": "Semaglutide vs tirzepatide vs oral"},
        {"day": 5, "topic": "A patient story (composite)"},
        {"day": 7, "topic": "5 mistakes people make"},
        {"day": 10, "topic": "Cost + how to start"},
        {"day": 14, "topic": "Last call — time-limited consult"}
      ]
    },
    {
      "id": "physician-handoff",
      "name": "Optional Physician-Evaluation Handoff (DrMedHealth)",
      "description": "Qualified users can opt into a same-day physician evaluation through DrMedHealth — LegitScript-certified GLP-1 telehealth operated by the same parent company.",
      "url": "https://drmedhealth.com",
      "category": "handoff",
      "opt_in_only": true,
      "automatic_data_passing": false,
      "partner_features": {
        "approval_time": "2-24 hours",
        "shipping": "1-2 days FREE",
        "coverage": "All 50 US states + DC + Guam",
        "compounded_semaglutide_monthly": 199,
        "compounded_tirzepatide_monthly": 299,
        "fda_approved_brands_available": ["Ozempic", "Wegovy", "Mounjaro", "Rybelsus"],
        "support": "24/7 board-certified physicians",
        "rating": "4.9/5 from 10,000+ reviews",
        "certifications": ["LegitScript Certified", "HIPAA Compliant"]
      }
    }
  ],
  "what_checkmyglp_does_not_do": [
    "Diagnose medical conditions",
    "Prescribe medications",
    "Establish a doctor–patient relationship",
    "Provide medical advice",
    "Replace primary care or emergency medical care",
    "Pass user data to third parties without explicit consent",
    "Sell user data",
    "Store medical answers (height, weight, conditions, medications, goals) in the database"
  ],
  "service_area": {
    "countries": ["United States"],
    "notes": "CheckMyGLP itself is web-accessible globally as an educational tool; the DrMedHealth handoff is US-only (all 50 states + DC + Guam)."
  },
  "audience": "Adults considering GLP-1 weight-loss medication who want to know if they meet FDA criteria before contacting a clinician or telehealth platform",
  "disclaimers": [
    "CheckMyGLP is an educational screening tool, not a medical diagnosis",
    "Final eligibility determination rests with a licensed physician",
    "Compounded GLP-1 medications referenced in the report are NOT FDA-approved",
    "Individual results may vary",
    "Testimonials are composite illustrations representing common user patterns",
    "Ozempic and Wegovy are registered trademarks of Novo Nordisk",
    "Mounjaro and Zepbound are registered trademarks of Eli Lilly"
  ]
}